A review of 11 randomized controlled trials looked at how virtual reality (VR) based training affects people diagnosed with Alzheimer's disease. The researchers compared patients using VR programs against a control group to see if the technology helped with different types of mental and physical tasks.
The study found that participants who used virtual reality showed significantly better global cognitive function and short-term memory than those in the control group. However, the research did not find significant improvements in other areas, such as executive function, spatial memory, balance, or quality of life.
It is important to note that the evidence for these findings is currently considered weak and limited because of a small sample size across the studies reviewed. While some cognitive benefits were seen, many other factors like depression levels and risk of falls did not show change. Patients should talk to their doctors about how these specific technologies might fit into their personal care plans.
Common questions
Can virtual reality help with memory loss in Alzheimer's?
The study found that patients using virtual reality based training showed significantly better short-term memory compared to those who did not use it. While this is a positive finding, the researchers noted that the overall evidence for these improvements is currently weak and limited due to small sample sizes.
Does virtual reality improve other symptoms of Alzheimer's?
The study found no significant improvements in several other areas. These included executive function, spatial memory, balance, coordination, fear of falling, and depression levels. Because the evidence is limited, these specific areas were not shown to improve with the training.
Is virtual reality safe for people with Alzheimer's?
The study did not report any specific adverse events or safety concerns regarding the use of virtual reality. However, because the evidence is still considered weak and limited by small sample sizes, you should consult a healthcare provider before starting new treatments.